CLSI I/LA25
Maternal Serum Screening, 2nd Edition
This document addresses the steps required to provide reliable screening and reporting using examples of serum markers currently in common use (AFP, hCG, uE3, inhibin A, PAPP-A). Emphasized is first-trimester screening, in which serum markers used are PAPP-A and hCG , and the main ultrasound marker is nuchal translucency. Outcome evaluation, information management, and calculation of risk are also emphasized.
This document is available in electronic format only.
Member price:
List Price:Details
Chairholder: Sanda Clejan, PhD
Date of Publication: April 28, 2011
Order Code PDF: CLSI ILA25A2E
ISBN Number: 1-56238-749-9
Order Code Print: print not available
Edition: Second
Pages: 64
CLSI I/LA25 Additional Details
This archived document is no longer being reviewed through the CLSI Consensus Document Development Process. However, this document is technically valid of as September 2023. Because of its value to the laboratory community, it is being retained in CLSI’s library.
If interested in ordering larger quantities of this document in print, please contact us here.